Navigation Links
Stimulant Medications More Effective In Treating ADHD Than Nonstimulants

Children with ADHD responded positively when treated with stimulant medications rather than nonstimulant medications or novel stimulants//. Researchers have proved that stimulant medications, such as mixed amphetamine salts (MAS) and methylphenidates are significantly more effective when compared with nonstimulant medications such as modafinil.

This conclusion is based on a meta-analysis of 29 controlled-treatment studies representing the past 25 years of research involving nearly 4,500 children with ADHD presented recently at the 2006 American Psychiatric Association meeting in Toronto, Canada.

Among stimulant medications classes, long-acting mixed amphetamine salts (MAS XR) and immediate-release mixed amphetamine salts showed a similar level of efficacy to short- or long-acting methylphenidates. The effectiveness of short- and long-acting stimulants did not differ from one another.

“The larger effect sizes we calculated for stimulant ADHD medications, compared to nonstimulants or the novel stimulant modafinil, leads us to conclude that amphetamine and methylphenidate based stimulant medications are more effective in treating symptoms of ADHD,” said Stephen V. Faraone, Ph.D., lead researcher and director of child and adolescent psychiatry at SUNY Upstate Medical University. “Our results should help physicians who have had to rely on qualitative comparisons among published trials, along with their own clinical experience, to draw conclusions about an ADHD medication’s relative efficacy because of largely absent direct head-to-head drug comparisons.”

The researchers compared study outcomes using effect sizes, a commonly used, standard statistical measure to determine the magnitude of a particular effect resulting from an intervention, such as a drug used on a population, irrespective of the population size. Effect sizes are generally categorized as small (0.2), medium (0.5) and large (0.8). Standardized mean averages, or effect sizes, for dependent measures in each study were computed by taking the mean of the active drug group minus the mean of the placebo group and dividing the result by the pooled standard deviation of the groups.

After adjusting for the influence of individual study design features, the researchers calculated effect size based on Total ADHD scores. Long-acting and short-acting stimulant medications showed the largest effect size among all medications (E = 0.83 and E = 0.9 respectively), followed by nonstimulant or modafinil based stimulants medications (E = 0.62). Statistically significant differences in effect size occurred in comparisons between nonstimulant/modafinil based stimulant medications and long-acting (p = 0.004) as well as short-acting stimulants (p = 0.002).

For the analysis, Faraone and his colleagues used data from 29 double-blind, placebo-controlled treatment studies of 4,465 children with ADHD, with an average age 10 years, published during or after 1980. Designs for all of the studies were randomized, double-blind with placebo controls that lasted for two or more weeks in populations diagnosed with ADHD as defined using criteria from the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition or Fourth Edition (DSM).

The analysis included 15 drugs using 17 different outcome measures of ADHD symptoms, including hyperactive, inattentive, impulsive or oppositional behavior. The most commonly identified treatments included both methylphenidate and amphetamine compounds. Nonstimulant drugs included in the analysis were atomoxetine, bupropion, modafinil and desipramine.

Source: Newsise
'"/>




Related medicine news :

1. Stimulants like coffee can help in reducing liver disease
2. Cocaine Acts As Suppressant Not Stimulant In Genetically Altered Mice
3. Coffee Stimulants Could Make us to Change The Attitude
4. Growth Hormone Stimulant Packs Healthy Aging
5. Growth Hormone Stimulants help to Combat Aging Symptoms
6. What happens when Medications go wrong?
7. Medications to Prevent Relapse to Cocaine Use
8. More Elderly Take Inappropriate and Harmful Medications
9. Medications for depression
10. Medications linked to xerostomia and caries
11. Analyzing The Side Effects Of Some Common Medications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading performance strength training ... of the Houston Rockets the NBSCA Strength & Conditioning Coach of the Year. ... members who vote to select the coach who embodies the highest level of excellence ...
(Date:6/27/2017)... ... 27, 2017 , ... A+ Orthodontics is now offering special ... on treating alignment and occlusion irregularities. Treatment often includes the use of braces ... Hollywood dentist , Dr. Garemani, along with Dr. Reza and the rest of ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... Children’s National ... Children’s Hospitals rankings, with its Neonatology program ranking #1 out of more than ... also named to the coveted Honor Roll, a distinction given to the top performing ...
(Date:6/26/2017)... ... ... Antoine Dental Center is now offering various types of dental implants to restore ... support for prosthetic teeth, such as crowns, bridges, or dentures. An implant is placed directly ... new root for the tooth. , Several types of dental implants are available, including: ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: